login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

Codman Neurovascular launches two new microcoil systems, new distal access catheter at SNIS


Thursday, 16 Aug 2012 10:20
Deltamaxx
Deltamaxx


Codman Neurovascular has announced the launch of the Deltamaxx Microcoil System, and Orbit Galaxy G2 Microcoils, which for the first time puts Orbit Galaxy coils on the EnpowerDetachment System, developed by Micrus Endovascular. Both new microcoil systems are now available in the United States and Europe. 


The announcement was made at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting where Codman Neurovascular featured the two new microcoil systems alongside the Envoy DA, a new distal access guiding catheter that facilitates navigation through tortuous portions of the carotid siphon and provides the stability required for complex neurointerventional procedures.


The DeltamaxxMicrocoil System features Codman’s Deltawindtechnology, a unique triangular wind shape with natural deflection points that enables the coil to change direction more easily than traditional circular wind coils. This is the longest microcoil the company has ever introduced, with lengths of up to 60cm. The coil is compatible with microcatheters with inner lumen diameters ranging from 0.0165” to 0.019”, such as Codman’s Prowlercatheters, which can also accommodate smaller finishing coils.


Codman Neurovascular also introduced Orbit Galaxy G2 Microcoils, a system of complex shaped, soft and highly conformable coils with random break points that has been shown to deliver high packing densities and result in low re-treatment rates. These new coils are deployed with the EnpowerDetachment System, a push-button thermomechanical detachment that streamlines the coiling procedure.


Finally, the company introduced the new Envoy DA Guiding Catheter, its first distal access guiding catheter, which features a braid design, soft distal tip, and hydrophilic coating and larger inner lumen.




Add New Comment

Related Items


Most popular


Revive SE thrombectomy device approved in China, South Korea and Taiwan
Monday, 08 Sep 2014
The Revive SE Device from Codman Neuro is designed to ease navigation through small and tortuous blood vessels and arteries in the cerebral vasculature. The new device enables rapid restoration of ... Revive SE thrombectomy device approved in China, South Korea and Taiwan

Monday, 08 Sep 2014
The Neuravi Thromboembolic Initiative brings together Neuravi engineers with clinicians and researchers in an effort to deepen the understanding of the mechanical properties of clot and occlusion ... Neuravi introduces collaborative clot research initiative at ESMINT

Aggressive resection should be considered for paediatric epilepsy
Thursday, 28 Aug 2014
Physicians from the University of California, San Francisco, USA, report that resection is safe and effective in children with pharmacoresistant focal epilepsy. Aggressive resection should be considered for paediatric epilepsy

Features


Neuro-oncologic treatment for glioblastoma
Monday, 21 Jul 2014
Malignant gliomas are the most common type of primary malignant brain tumour, accounting for 80% of patients and an annual incidence of 5.26 per 100,000 population, or 17,000 new cases diagnosed per ... Neuro-oncologic treatment for glioblastoma

Early brain stimulation may help stroke survivors recover language function
Monday, 21 Jul 2014
Dieter Heiss, who presented on early brain stimulation for stroke patients at the 8th World Congress on Controversies in Neurology (CONy), 8–11 May, Berlin, Germany, writes for NeuroNews on how this ... Early brain stimulation may help stroke survivors recover language function

Profiles


Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

Mauricio Castillo
Monday, 14 Jul 2014
Mauricio Castillo is a professor of Radiology and chief, Division of Neuroradiology, University of N... Mauricio Castillo

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions